[1] |
|
[2] |
|
[3] |
王进进,施辉,董文胜,等.微创钻孔引流联合尿激酶和阿托伐他汀对慢性硬膜下血肿患者术后神经功能及复发率的影响[J].脑与神经疾病杂志, 2021, 29(4): 222-227.
|
[4] |
Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma[J]. Neurosurg Rev, 2012, 35(2): 155-169; discussion 169. DOI: 10.1007/s10143-011-0349-y.
|
[5] |
|
[6] |
Wan Y, Fei X, Jiang D, et al. Clinical observation of treatment of chronic subdural hematoma with novel double needle minimally invasive aspiration technology[J]. J Craniofac Surg, 2017, 28(3): 646-649. DOI: 10.1097/scs.0000000000003462.
|
[7] |
Abecassis IJ, Kim LJ. Craniotomy for treatment of chronic subdural hematoma[J]. Neurosurg Clin N Am, 2017, 28(2): 229-237. DOI: 10.1016/j.nec.2016.11.005.
|
[8] |
Desai VR, Scranton RA, Britz GW. Management of recurrent subdural hematomas[J]. Neurosurg Clin N Am, 2017, 28(2): 279-286. DOI: 10.1016/j.nec.2016.11.010.
|
[9] |
|
[10] |
|
[11] |
Kim J, Moon J, Kim T, et al. Risk factor analysis for the recurrence of chronic subdural hematoma: a review of 368 consecutive surgical cases[J]. Korean J Neurotrauma, 2015, 11(2): 63-69. DOI: 10.13004/kjnt.2015.11.2.63.
|
[12] |
|
[13] |
Wang D, Li T, Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336(1-2): 237-242. DOI: 10.1016/j.jns.2013.11.005.
|
[14] |
Xu M, Chen P, Zhu X, et al. Effects of atorvastatin on conservative and surgical treatments of chronic subdural hematoma in patients[J]. World Neurosurg, 2016, 91: 23-28. DOI: 10.1016/j.wneu.2016.03.067.
|
[15] |
Jiang R, Zhao S, Wang R, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinicaltrial[J]. JAMA Neurol, 2018, 75(11): 1338-1346. DOI: 10.1001/jamaneurol.2018.2030.
|
[16] |
|